On Thursday, Shares of CryoLife Inc. (NYSE: CRY) gained 0.44% to $29.41. The stock grabbed the investor’s attention and traded 33.219K shares as compared to its average daily volume of 216.70K shares. The stock’s institutional ownership stands at 72.00%.
CryoLife, Inc. (CRY) declared recently its financial results for the first quarter ended March 31, 2019.
First Quarter 2019 Financial Results:
Total revenues for the first quarter of 2019 were $67.50M, reflecting growth of 9%, and 11% on a non-GAAP constant currency basis, both contrast to the first quarter of 2018. The increase was driven by strong revenue growth from JOTEC, On-X, and BioGlue.
Net loss for the first quarter of 2019 was ($297.0K), or ($0.01) per fully diluted common share, contrast to a net loss of ($3.90)M, or ($0.11) per fully diluted common share for the first quarter of 2018. Non-GAAP net income for the first quarter of 2019 was $1.50M, or $0.04 per fully diluted common share, contrast to non-GAAP net income of $793.0K, or $0.02 per fully diluted common share for the first quarter of 2018.
2019 Financial Outlook:
CryoLife is reiterating its full-year financial guidance, with total revenues for 2019 expected to be in the range of $280.0M to $284.0M and non-GAAP earnings per share expected to be between $0.28 and $0.32.
CRY has a market value of $1.07B while its EPS was booked as $0.01 in the last 12 months. The stock has 36.70M shares outstanding. In the profitability analysis, the company has gross profit margin of 66.30%. Beta value of the company was 0.60; beta is used to measure riskiness of the security. Analyst recommendation for this stock stands at 1.70.